婴儿血管瘤(IH)是婴儿期最常见的良性肿瘤,临床多见。虽然有部分IH存在自然消退过程,但少数IH仍需要有效治疗,以防止其对皮肤的损害,导致肢体功能障碍以及发生局部溃疡。治疗方法多种多样,目前洛尔类制剂以其安全高效的优点成为一线首选药物。本文将对不同洛尔类制剂在婴幼儿血管瘤的临床应用进行综述。 Infantile hemangioma (IH) is the most common benign tumor in infancy, more common clinical. Although some of the IH have a natural extinction process, but a few IH still need effective treatment to prevent its damage to the skin, resulting in limb dysfunction and the occurrence of local ulcers. A variety of treatment methods, the current class of agents with its safe and efficient advantages of becoming first-line drug. This article will review the clinical application of different kinds of Lorne preparations in infantile hemangiomas.